Rhythm Pharmaceuticals, Inc. (RYTM) Earnings Call Transcript & Summary

June 17, 2020

NASDAQ US Health Care Biotechnology shareholder_meeting 7 min

Earnings Call Speaker Segments

Operator

operator
#1

Good afternoon. Hello, and welcome to the Annual Meeting of Stockholders of Rhythm Pharmaceuticals, Inc. Please note that today's meeting is being recorded. [Operator Instructions] It is now my pleasure to turn today's meeting over to David Meeker, Chairman of the Rhythm Board of Directors.

David Meeker

executive
#2

Good afternoon. I am David Meeker, Chairman of the Board of Directors of Rhythm Pharmaceuticals and Chairperson of today's meeting. Let me take this opportunity to welcome all those attending our 2020 annual meeting of stockholders which we are holding virtually in light of the COVID-19 pandemic. Before the meeting is called to order, I'd like to introduce to you the other members of the Board and officers of the company who are on the webcast today. From the Board are: Stuart Arbuckle; Todd Foley; Jennifer Good; Christophe Jean; Ed Mathers; and David McGirr. From the company, we also have Hunter Smith, our Interim President and Chief Executive Officer and Chief Financial Officer, Treasurer and Secretary. I would also like to introduce Jon Lang of Ernst & Young LLP, the company's independent registered public accountants, who is available to respond to appropriate questions via the question-and-answer function on the annual meeting web page. As well as Nicole McNeil of Latham & Watkins, counsel to the company, who will act as secretary of today's meeting. I will now turn the meeting over to Hunter Smith, who will conduct the formal part of the meeting.

Hunter Smith

executive
#3

Thank you, David. I will now call the meeting to order. We will proceed with the formal business of the meeting as indicated in the notice of annual meeting and the company's proxy statement. The polls open today, June 17, 2020, at 2:00 p.m. Eastern Time for voting on all matters before the meeting. If you have not already voted and wish to vote, the polls will remain open until we finish presenting the proposals and close the poll. You do not need to vote during the meeting if you have already voted and do not wish to change your vote. On the virtual meeting web page, you will find the agenda for the meeting. You will also find the rules of conduct for today's meeting. Please review these rules carefully. Note that only stockholders who are logged into the meeting using their 15 digit control number will be able to vote and submit questions at today's meeting. The secretary will file the proof of mailing notice of the meeting with the records of the meeting. All stockholders of record at the close of business on April 20, 2020, or holders of a valid proxy are entitled to vote at today's meeting. The inspector of election has a complete list of the holders of record of the company's common stock on the record date for the meeting and for verified stockholders. At this time, I'd like to introduce Patti Peachey of Computershare Trust Company NA, who will serve as the inspector of election at today's meeting. Ms. Peachey has signed the customary oath as inspector of election to execute her duties with strict impartiality. The oath shall be filed with the minutes of the meeting. Ms. Peachey has informed me that there are present at the meeting online or represented by proxy, the holders of the majority of the total number of shares of common stock of the company outstanding and entitled to vote at the meeting. There is therefore, a quorum present, and I hereby declare this meeting to be duly constituted for the transaction of business. There are 2 items of business to be considered by the stockholders at today's meeting. The Board recommends that the stockholders vote for each of the proposals. The first item of business is the proposed election of David W. J. McGirr and David P. Meeker, MD, as Class III Directors for a term ending in 2023. The second item of business is the proposal to ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2020. That was the final item of business for today's meeting. If you wish to vote and you haven't done so already, please vote now by clicking on the voting button on the web portal and following the instructions. You do not need to vote electronically if you have already sent in your signed proxy or if you have voted by telephone or Internet. We will pause for approximately 30 seconds before closing the voting polls. [Voting]

Hunter Smith

executive
#4

The time is now 2:05 p.m. on June 17, 2020, and the polls are now closed for voting. We will pause for a moment while the inspector of election makes her final tabulation of votes. I have received the preliminary report of the inspector of election, and the final report of the inspector of election will be kept with the company's records of the annual meeting. Based on the preliminary report of the inspector of election, David W. J. McGirr and David P. Meeker, MD have been duly elected as Class III Directors of the company to serve until the Annual Meeting of Stockholders for fiscal year 2023 and until their respective successors have been duly elected and qualified. And the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2020, has been ratified by the stockholders of the company. The final tally of the votes will be published within 4 business days in a current report on Form 8-K to be filed with the Securities and Exchange Commission. Is there any further business to come before the meeting? If there is no further business, the legal portion of the meeting is now adjourned. The meeting is now open for any questions or comments relating to the business of the company via the online portal. [Operator Instructions] Please also note that Jon Lang, a representative of Ernst & Young LLP, the company's independent auditor, is present at the meeting and available to respond to the questions raised by stockholders. David Connolly, are there any questions that have been submitted?

David Connolly

executive
#5

No, there are no questions. Please proceed with your closing remarks.

Hunter Smith

executive
#6

Ladies and gentlemen, that concludes the annual meeting. Thank you all very much for participating. Operator, I turn it back to you.

Operator

operator
#7

This concludes the meeting. You may now disconnect.

For developers and AI pipelines

Programmatic access to Rhythm Pharmaceuticals, Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.